A drug with the SMILES CC(C)n1c(N2CCN(S(=O)(=O)c3cccc([N+](=O)[O-])c3)CC2)nc2ccccc21 has a human ether-à-go-go related gene (hERG) inhibition at 1uM of -21.313\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
CC(C)n1c(N2CCN(S(=O)(=O)c3cccc([N+](=O)[O-])c3)CC2)nc2ccccc21
CC(C)n1c(N2CCN(S(=O)(=O)c3cccc([N+](=O)[O-])c3)CC2)nc2ccccc21
2-[4-(3-nitrophenyl)sulfonylpiperazin-1-yl]-1-propan-2-ylbenzimidazole